Evidence map›Paper›PMID 39620586›Full record

ReviewImmunological reviews2025

Established and Emerging Roles of DEAD/H-Box Helicases in Regulating Infection and Immunity.

Michael Parthun, Matthew E Long, Emily A Hemann

Abstract readReview
In one paragraph

Review in Immunological reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. RNA helicase DDX3X promotes NK cell survival by supporting MCL1 expression.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael ParthunDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Matthew E LongDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Emily A HemannDepartment of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA.ORCID 0000-0002-6398-3492

Funding

RIG-I-like receptor regulation of pulmonary inflammation and homeostasisR35GM150503 · NIGMS · OHIO STATE UNIVERSITY · PI Emily Ann Hemann · 2023 to 2026
$1.6M
NON-CANONICAL MECHANISMS FOR INTERFERON-LAMBDA REGULATION OF SARS-COV-2 INFECTIONR21AI174050 · NIAID · OHIO STATE UNIVERSITY · PI HEMANN, EMILY ANN · 2023 to 2024
$413k
NIAID NIH HHS R21 AI174050NIGMS NIH HHS R35 GM150503
6 · The paper itself

Abstract

The sensing of nucleic acids by DEAD/H-box helicases, specifically retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated protein 5 (MDA5), plays a critical role in inducing antiviral immunity following infection. However, this DEAD/H-box helicase family includes many additional proteins whose immune functions have not been investigated. While numerous DEAD/H-box helicases contribute to antiviral immunity, they employ diverse mechanisms beyond the direct sensing of nucleic acids. Some members have also been identified to play proviral (promoting virus replication/propagation) roles during infections, regulate other non-viral infections, and contribute to the regulation of autoimmunity and cancer. This review synthesizes the known and emerging functions of the broader DEAD/H-box helicase family in immune regulation and highlights ongoing efforts to target these proteins therapeutically.

Indexed as

DEAD-box RNA HelicasesInfectionsVirus DiseasesAnimalsHost-Pathogen InteractionsHumansImmunityImmunity, InnateDEAD-box RNA HelicasesDEAD‐box helicasesimmunityinfectioninterferonRLRs

Identifiers

PMID39620586
PMCPMC11741935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.